NeuroScientific Biopharmaceuticals Limited (ASX:NSB)

Market Cap	46.56M
Revenue (ttm)	2.21M
Net Income (ttm)	1.19M
Shares Out	332.58M
EPS (ttm)	0.01
PE Ratio	17.28
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	53,663
Average Volume	482,608
Open	0.1400
Previous Close	0.1300
Day's Range	0.1300 - 0.1400
52-Week Range	0.0330 - 0.1400
Beta	1.32
RSI	81.51
Earnings Date	Aug 25, 2025

About ASX:NSB

NeuroScientific Biopharmaceuticals Limited engages in the research and development of novel peptide-based pharmaceutical products. The company is involved in the development of therapeutic treatments for neurodegenerative diseases through preclinical and clinical studies of patented technologies. Its lead drug candidates include EmtinB for treatment of neurodegenerative Alzheimer’s disease, multiple scierosis, glaucoma, optic nerve atrophy, and other diseases. The company was incorporated in 2002 and is based in Perth, Australia.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: NSB